Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01094574 · ClinicalTrials.gov registry record · NA
Evaluation of Propranolol's Effect on Pain and Inflammation.
A NA study, sponsored by Martin Angst.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT01094574 is a NA study that has completed, run by Martin Angst. The registered enrollment target is 10 participants.
The verdict
NCT01094574, a NA study, has completed, sponsored by Martin Angst.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Previous studies have shown that the beta-adrenergic system plays a role in processing pain and the expression of hyperalgesia. Recent studies have investigated the analgesic effects, and potential anti-hyperalgesic effects (using a model of opioid induced (OIH) hyperalgesia) of propranolol, a beta adrenergic antagonist. We plan to further investigate the analgesic effects, and the potential anti inflammatory effects, of propranolol and compare those effects to alfentanil, an opioid of known effect, and placebo
Interventions
- DRUG Placebo
- DRUG Propranolol
- DRUG Alfentanil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2010-01 |
| Est. Completion | 2010-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01094574
The ClinicalTrials.gov registry entry for NCT01094574 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Martin Angst, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01094574 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01094574 about?
NCT01094574 is a clinical study titled "Evaluation of Propranolol's Effect on Pain and Inflammation.". Previous studies have shown that the beta-adrenergic system plays a role in processing pain and the expression of hyperalgesia. Recent studies have investigated the analgesic effects, and potential anti-hyperalgesic effects (using a model of opioid induced (OIH) hyperalgesia) of propranolol, a beta ...
What is the current status of trial NCT01094574?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2010-01. Estimated completion is 2010-08.
What interventions are being tested in trial NCT01094574?
The interventions under investigation include: Placebo (DRUG), Propranolol (DRUG), Alfentanil (DRUG).
Who is sponsoring clinical trial NCT01094574?
This trial is sponsored by Martin Angst, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.